North America Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
The North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to grow at a CAGR of 13.1% from 20... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to grow at a CAGR of 13.1% from 2022 to 2030.Commercial Use of Single-Use Bioreactors Fuels North America Upstream Bioprocessing Market. Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market. North America Upstream Bioprocessing Market Overview The upstream bioprocessing market in North America is segmented into the US, Canada, and Mexico. Market growth in North America is attributed to the increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, the prominent presence of market players, and growing R&D efforts by academic and research institutes. In addition, research activities by pharmaceutical and biotechnology companies propel the upstream bioprocessing market growth in North America. North America Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million) North America Upstream Bioprocessing Market Segmentation The North America upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022. Based on workflow, the North America upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022. In terms of usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022 By mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022. Based on country, the North America upstream bioprocessing market is segmented into the US, Canada, and Mexico. The US dominated the North America upstream bioprocessing market share in 2022. Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc are some of the leading companies operating in the North America upstream bioprocessing market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. North America Upstream Bioprocessing Market Landscape 4.1 Overview 4.2 PEST Analysis 5. North America Upstream Bioprocessing Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Commercial Use of Single-Use Bioreactors 5.1.2 Outsourcing of Biopharmaceutical Manufacturing 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries 5.2 Market Restraints 5.2.1 Stringent Regulatory Framework 5.3 Market Opportunities 5.3.1 Technological Advancements 5.4 Future Trends 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry 5.5 Impact of Drivers and Restraints: 6. Upstream Bioprocessing Market - North America Analysis 7. North America Upstream Bioprocessing Market Analysis - by Product Type 7.1 Bioreactors/Fermenters 7.1.1 Overview 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.2 Cell Culture 7.2.1 Overview 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Filters 7.3.1 Overview 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Bags and Containers 7.4.1 Overview 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.5 Others 7.5.1 Overview 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8. North America Upstream Bioprocessing Market Analysis - by Workflow 8.1 Media Preparation 8.1.1 Overview 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.2 Cell Culture 8.2.1 Overview 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Cell Separation 8.3.1 Overview 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9. North America Upstream Bioprocessing Market Analysis - by Usage Type 9.1 Single-use 9.1.1 Overview 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9.2 Multi-use 9.2.1 Overview 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10. North America Upstream Bioprocessing Market Analysis - by Mode 10.1 In-house 10.1.1 Overview 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10.2 Outsourced 10.2.1 Overview 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11. North America Upstream Bioprocessing Market - Country Analysis 11.1 North America Market Overview 11.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.2 US 11.1.1.3 US: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.4 Canada 11.1.1.5 Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.6 Mexico 11.1.1.7 Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in Upstream Bioprocessing Market 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 Thermo Fisher Scientific Inc 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Esco Micro Pte. Ltd. 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 Sartorius AG 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Danaher Corp 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 Getinge AB 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Merck KGaA 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Corning Inc 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 13.8 Entegris, Inc. 13.8.1 Key Facts 13.8.2 Business Description 13.8.3 Products and Services 13.8.4 Financial Overview 13.8.5 SWOT Analysis 13.8.6 Key Developments 13.9 PBS Biotech, Inc. 13.9.1 Key Facts 13.9.2 Business Description 13.9.3 Products and Services 13.9.4 Financial Overview 13.9.5 SWOT Analysis 13.9.6 Key Developments 14. Appendix 14.1 About The Insight Partners 14.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(映画・娯楽)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(media)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/22 10:26 151.74 円 164.56 円 199.74 円 |